Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bal Pharma has informed that it submitted the details of businesses transacted at the 34rd Annual General Meeting of the Company conducted through audio visual means, on 24.09.2021. Shailesh Siroya was elected as Chairman and he chaired the proceedings of the meeting with requisite quorum. Ordinary and special businesses are enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.90 |
| Dr. Reddys Lab | 1222.90 |
| Cipla | 1231.00 |
| Zydus Lifesciences | 932.25 |
| Lupin | 2327.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: